Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD," aimed at stimulating research on HIV/AIDS, particularly in relation to communication disorders affecting individuals living with HIV. This initiative encourages applications that address high-priority research areas outlined by the NIH Office of AIDS Research, focusing on aspects such as hearing, balance, taste, smell, voice, speech, and language, with an emphasis on low-risk clinical trials that do not require FDA oversight. The funding available through R21 Exploratory/Developmental Research Grants amounts to a total of $275,000 for a two-year project period, with applications due by January 7, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.